Skip to main content

Table 4 Association between LIMK1 IHC score and clinicopathological features of CRC patients

From: Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes

Features

n

LIMK1 IHC score, n (%)

χ2 value

P-valuea

Low

High

Gender

 Male

23

11(47.8)

12(52.2)

0.023

0.879

 Female

26

13(50)

13(50)

  

Age at surgery (years)

 ≥ 65

27

13(48.1)

14(51.9)

0.016

0.897

 < 65

22

11(50)

11(50)

  

Localization

 Colon ascendens

14

5(35.7)

9(64.3)

5.761

0.123

 Colon descendens

10

5(50)

5(50)

  

 Colon transversum

3

0

3(100)

  

 Colon sigmoideum/rectum

22

14(63.6)

8(36.4)

  

Tumor type

 Adenocarcinoma

40

21(52.5)

19(47.5)

1.080

0.298

 Adenocarcinoma/mucinous

9

3(33.3)

6(66.7)

  

Tumor grade

 Well differentiated

1

1(100)

0

4.003

0.135

 Moderately differentiated

45

23(51.1)

22(48.9)

  

 Poorly differentiated

3

0

3(100)

  

T stage (AJCC)

 T1/2

15

7(46.7)

8(53.3)

0.046

0.977

 T3

16

8(50)

8(50)

  

 T4

18

9(50)

9(50)

  

Lymph node metastasis

0.032

0.857

 Present

19

9(47.4)

10(52.6)

  

 Absent

30

15(50)

15(50)

  

Liver metastasis

 Present

13

7(53.9)

6(46.1)

0.167

0.682

 Absent

36

17(47.2)

19(52.8)

  

Lymphovascular invasion

 Present

13

6(46.1)

7(53.9)

0.056

0.812

 Absent

36

18(50)

18(50)

  

Perineural invasion

 Present

11

6(54.5)

5(45.5)

0.012

0.910

 Absent

38

20(52.6)

18(47.4)

  

Tumor size (cm3)

 ≥ 33

24

13(54.1)

11(45.9)

0.506

0.476

 < 33

25

11(44)

14(56)

  
  1. aP value obtained from χ2 test
  2. CRC colorectal cancer, AJCC American Joint Committee on Cancer